# Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11
Canonical URL: https://biopharmsignal.com/news/HLF/herbalife-chief-financial-officer-to-present-at-east-coast-ideas-conference-on-june-11
Ticker: HLF
Company: Herbalife Nutrition
Source: Herbalife Nutrition
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.herbalife.com
## Summary

LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will present at the East Coast I...

## Article Body
LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will present at the East Coast IDEAS Conference on Thursday, June 11, 2026 at 10:35 a.m. ET (7:35 a.m. PT).

The live webcast will be available at the following link: https://event.summitcast.com/view/GAjb2PfaSPbv9ViGy3AtzN/ZC5vwyKUXDsTKS4G6iXFet

A link to the webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/ . A replay of the webcast will be available at the same website following the completion of the event and for six months thereafter.

Additional information regarding the East Coast IDEAS Conference in New York City is available at www.IDEASconferences.com .

About Herbalife Ltd.

Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.

For more information, visit https://ir.herbalife.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20260602558849/en/

Media Contact: Miguel Lopez-Najera

Director, Global Corporate Communications

miguellope@herbalife.com

Investor Contact: Erin Banyas

Vice President, Head of Investor Relations

erinba@herbalife.com

Source: Herbalife Ltd.

Released Jun 2, 2026 • 7:05 am ET
## Recent Company News
- 2026-07-20 11:05 EST — [Herbalife CFO to Participate in Maxim Group “Health, Wellness & Longevity” Virtual Conference on July 22](https://biopharmsignal.com/news/HLF/herbalife-cfo-to-participate-in-maxim-group-health-wellness-longevity-virtual-co-145c5335) — Source: Herbalife Nutrition
- 2026-07-13 18:59 EST — [Herbalife Named to TIME's List of America’s Best Companies 2026](https://biopharmsignal.com/news/HLF/herbalife-named-to-time-s-list-of-america-s-best-companies-2026-14afe60c) — Source: Herbalife Nutrition
- 2026-07-01 11:05 EST — [Herbalife to Announce Second Quarter 2026 Results on August 5](https://biopharmsignal.com/news/HLF/herbalife-to-announce-second-quarter-2026-results-on-august-5-b85d8156) — Source: Herbalife Nutrition
- 2026-06-25 13:46 EST — [Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists](https://biopharmsignal.com/news/HLF/herbalife-named-to-three-2026-usa-today-most-trusted-brands-lists) — Source: Herbalife Nutrition
- 2026-06-25 13:46 EST — [Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11](https://biopharmsignal.com/news/HLF/herbalife-chief-financial-officer-to-present-at-east-coast-ideas-conference-on-june-11) — Source: Herbalife Nutrition
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)